Srimathi Srinivasan

5PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 18, 2025
Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status.

Ciara L Freeman, Srimathi Srinivasan, Brendan Hodkinson

|Apr 27, 2024
A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer.

Nora D Mineva, Stefania Pianetti, Sonia G Das

|Dec 11, 2023
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition.

Alan Cooper, Sravya Tumuluru, Kyle Kissick

|Jun 06, 2023
Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study.

Talha Munir, Carol Moreno, Carolyn Owen

|Mar 13, 2023
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners.

Aatman S Doshi, Susan Cantin, Marylens Hernandez

Pageof 1

Frequent Collaborators

2 joint publications

David W Scott

1 joint publications

Aatman S Doshi

1 joint publications

Susan Cantin

1 joint publications

Marylens Hernandez